DeepMind's Isomorphic Labs Raises at $40B Valuation, Testing AI Drug Discovery Without Patient Data
Isomorphic Labs, an Alphabet Inc. company using AI to discover drugs and spun out of Google DeepMind, is in early talks to raise new funds at a valuation of at least $40 billion, potentially reaching $50 billion. The company, spun out of Google DeepMind in 2021, has yet to put a single AI-designed drug into a human being, with the markup happening ahead of any clinical proof that the approach works in patients.
The White House announced a $1 billion commitment in AI computing credits from firms including AMD and OpenAI to support federal scientific research.
Prime Minister Narendra Modi, while inaugurating India Mobile Congress on October 8, called for a global framework to tackle cyber fraud and deepfakes, arguing that digital threats increasingly cross national boundaries.
Shanghai Biren Technology said on October 8 it will place 130 million new H-shares at HK$31.08 apiece, raising about $515 million, its third capital raise since its January IPO following a July placement that raised about $892.5 million.
Did you know?
Mistral's new 1-trillion-parameter model, 'Le Chonk,' was remarkably trained using only 3,800 NVIDIA Grace Blackwell GPUs.
Quiz
What is the official nickname of the trillion-parameter model Mistral AI unveiled this week?